Genetic variations in microRNAs and the risk and survival of renal cell cancer

Carcinogenesis

Volumn 35, Issue 7, 2014, Pages

  Mulong Du, Mulong ^a,b   Lu, Desheng ^c   Wang, Qiaoyan ^a,b   Chu, Haiyan ^a,b   Tong, Na ^a,b   Pan, Xuping ^c   Qin, Chao ^d   Yin, Changjun ^d   Wang, Meilin ^a,b   Zhang, Zhengdong ^a,b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Nanjing Medical University   (China)

^c THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^d THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Genetic variations; MicroRNA; Renal cell cancer; Risk and survival

Indexed keywords

MICRORNA; MICRORNA 146A; MICRORNA 149; MICRORNA 196A; MICRORNA 499; TUMOR MARKER; UNCLASSIFIED DRUG; MIRN196 MICRORNA, HUMAN;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CANCER TISSUE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GENOTYPING TECHNIQUE; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; LUCIFERASE ASSAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL RATE; CANCER GRADING; CANCER STAGING; FOLLOW UP; GENETICS; KIDNEY TUMOR; MIDDLE AGED; MORTALITY; PAPILLARY CARCINOMA; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR;

CARCINOMA, PAPILLARY; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; KIDNEY NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84904018650     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu082     Document Type: Article

References (38)

1. Chow, W.H., et al. (2010) Epidemiology and risk factors for kidney cancer. Nat Rev Urol, 7, 245-57.
2. Siegel, R., et al. (2013) Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30.
3. Kume, H., et al. (2001) Risk factors for adult renal cell carcinoma: a systematic review and implications for prevention. BJU Int, 88, 804.
4. Nicodemus, K.K., et al. (2004) Evaluation of dietary, medical and lifestyle risk factors for incident kidney cancer in postmenopausal women. Int J Cancer, 108, 115-21.
5. Beebe-Dimmer, J.L., et al. (2012) Body mass index and renal cell cancer: the influence of race and sex. Epidemiology, 23, 821-8.
6. Chen, C.Z., et al. (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science, 303, 83-6.
7. Baroukh, N., et al. (2007) MicroRNA-124a regulates Foxa2 expression and intracellular signaling in pancreatic beta-cell lines. J Biol Chem, 282, 19575-88.
8. Carissimi, C., et al. (2009) MicroRNAs: novel regulators of immunity. Autoimmun Rev, 8, 520-4.
9. Ruvkun, G. (2006) Clarifications on miRNA and cancer. Science, 311, 36-7.
10. Tavazoie, S.F., et al. (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature, 451, 147-52.
11. Lu, J., et al. (2005) MicroRNA expression profiles classify human cancers. Nature, 435, 834-8.
12. Nakada, C., et al. (2008) Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. J Pathol, 216, 418-27.
13. Weng, L., et al. (2010) MicroRNA profiling of clear cell renal cell carcinoma by whole-genome small RNA deep sequencing of paired frozen and formalin-fixed, paraffin-embedded tissue specimens. J Pathol, 222, 41-51.
14. Moore, L.E., et al. (2011) Von Hippel-Lindau (VHL) inactivation in sporadic clear cell renal cancer: associations with germline VHL polymorphisms and etiologic risk factors. PLoS Genet, 7, e1002312.
15. Gardie, B., et al. (2011) Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma. J Med Genet, 48, 226-34.
16. Ryan, B.M., et al. (2010) Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer, 10, 389-402.
17. Cai, H., et al. (2012) A Functional Insertion/Deletion Polymorphism (-94 ins/del ATTG) in the Promoter Region of the NFKB1 Gene Is Related to the Risk of Renal Cell Carcinoma. Urol Int.
18. Wang, M., et al. (2012) Genetic variants in miRNAs predict bladder cancer risk and recurrence. Cancer Res, 72, 6173-82.
19. Betel, D., et al. (2008) The microRNA.org resource: targets and expression. Nucleic Acids Res, 36, D149-53.
20. Maragkakis, M., et al. (2011) DIANA-microT Web server upgrade supports Fly and Worm miRNA target prediction and bibliographic miRNA to disease association. Nucleic Acids Res, 39, W145-8.
21. Wang, X. (2008) miRDB: a microRNA target prediction and functional annotation database with a wiki interface. RNA, 14, 1012-7.
22. Rushing, E.C., et al. (2012) Neuropilin-2: a novel biomarker for malignant melanoma? Hum Pathol, 43, 381-9.
23. Mizutani, Y., et al. (2003) Significance of thymidylate synthase activity in renal cell carcinoma. Clin Cancer Res, 9, 1453-60.
24. Hu, Z., et al. (2008) Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest, 118, 2600-8.
25. Griffiths-Jones, S., et al. (2006) miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res, 34, D140-4.
26. Croce, C.M., et al. (2005) miRNAs, cancer, and stem cell division. Cell, 122, 6-7.
27. Calin, G.A., et al. (2002) Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A, 99, 15524-9.
28. Hoffman, A.E., et al. (2009) microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res, 69, 5970-7.
29. Christensen, B.C., et al. (2010) Mature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer. Clin Cancer Res, 16, 3713-20.
30. Ahn, D.H., et al. (2012) Association of the miR-146aC>G, miR-149T>C, miR-196a2T>C, and miR-499A>G polymorphisms with gastric cancer risk and survival in the Korean population. Mol Carcinog.
31. Wang, S., et al. (2013) A functional polymorphism in MIR196A2 is associated with risk and prognosis of gastric cancer. Mol Carcinog.
32. Srivastava, K., et al. (2010) Common genetic variants in pre-microRNAs and risk of gallbladder cancer in North Indian population. J Hum Genet, 55, 495-9.
33. Hezova, R., et al. (2012) Evaluation of SNPs in miR-196-a2, miR-27a and miR-146a as risk factors of colorectal cancer. World J Gastroenterol, 18, 2827-31.
34. Horikawa, Y., et al. (2008) Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. Clin Cancer Res, 14, 7956-62.
35. Hirschhorn, J.N., et al. (2002) A comprehensive review of genetic association studies. Genet Med, 4, 45-61.
36. Bloomston, M., et al. (2007) MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA, 297, 1901-8.
37. Wild, J.R., et al. (2012) Neuropilins: expression and roles in the epithelium. Int J Exp Pathol, 93, 81-103.
38. Hu, H.B., et al. (2012) Predictive value of thymidylate synthase expression in gastric cancer: a systematic review with meta-analysis. Asian Pac J Cancer Prev, 13, 261-7.